NCT03459014

Brief Summary

The aim of this study is to investigate the effect of manipulating the optic flow (OF) speed in 2 different virtual environments (VE) on active participation in healthy participants during virtual reality (VR) - enhanced robot-assisted gait(RAG). The second aim is to investigate the effect of two different VEs on active participation during RAG.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Sep 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 19, 2018

Completed
17 days until next milestone

First Posted

Study publicly available on registry

March 8, 2018

Completed
6 months until next milestone

Study Start

First participant enrolled

September 12, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 13, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 13, 2019

Completed
Last Updated

April 24, 2019

Status Verified

April 1, 2019

Enrollment Period

7 months

First QC Date

February 19, 2018

Last Update Submit

April 23, 2019

Conditions

Keywords

Robot-Assisted Gait TrainingVirtual RealityOptic FlowActive Participation

Outcome Measures

Primary Outcomes (9)

  • Muscle activity (EMG)

    Muscle activity will be measured continuously during the 21 minutes of testing. Average muscle activity (%MVIC) will be measured at different time frames. Offline calculation (e.g. averages) will be performed afterwards.

    Every minute of the 21-minute session.

  • Interaction torques left hip

    Interaction torques will be measured continuously during the 21 minutes of testing. Average interaction torques (Nm) between participant and device will be measured at different time frames. Offline calculation (e.g. averages) will be performed afterwards.

    Every minute of the 21-minute session.

  • Interaction torques left knee

    Interaction torques will be measured continuously during the 21 minutes of testing. Average interaction torques (Nm) between participant and device will be measured at different time frames. Offline calculation (e.g. averages) will be performed afterwards.

    Every minute of the 21-minute session.

  • Interaction torques right hip

    Interaction torques will be measured continuously during the 21 minutes of testing. Average interaction torques (Nm) between participant and device will be measured at different time frames. Offline calculation (e.g. averages) will be performed afterwards.

    Every minute of the 21-minute session.

  • Interaction torques right knee

    Interaction torques will be measured continuously during the 21 minutes of testing. Average interaction torques (Nm) between participant and device will be measured at different time frames. Offline calculation (e.g. averages) will be performed afterwards.

    Every minute of the 21-minute session.

  • Range of motion left hip

    Range of motion will be measured continuously during the 21 minutes of testing. Average range of motion (°) will be measured at different time frames. Offline calculation (e.g. averages) will be performed afterwards.

    Every minute of the 21-minute session.

  • Range of motion left knee

    Range of motion will be measured continuously during the 21 minutes of testing. Average range of motion (°) will be measured at different time frames. Offline calculation (e.g. averages) will be performed afterwards.

    Every minute of the 21-minute session.

  • Range of motion right hip

    Range of motion will be measured continuously during the 21 minutes of testing. Average range of motion (°) will be measured at different time frames. Offline calculation (e.g. averages) will be performed afterwards.

    Every minute of the 21-minute session.

  • Range of motion right knee

    Range of motion will be measured continuously during the 21 minutes of testing. Average range of motion (°) will be measured at different time frames. Offline calculation (e.g. averages) will be performed afterwards.

    Every minute of the 21-minute session.

Study Arms (2)

Stimulus rich VE

EXPERIMENTAL

Participants will be tested during 1 RAG session in the Lokomat. Participants in the experimental group will walk in a stimulus rich VE such as walking in a park.

Other: Stimulus rich VE

Stimulus poor VE

ACTIVE COMPARATOR

Participants will be tested during 1 RAG session in the Lokomat. Participants in the control group will walk in a stimulus poor VE, such as walking through an endless hallway.

Other: Stimulus poor VE

Interventions

Participants will walk in the Lokomat with the VR for 21 minutes. After every 7 minutes, the speed of the OF will change (2 times the comfortable walking speed, equally to the comfortable walking speed, and 0.5 times the comfortable walking speed).

Stimulus rich VE

Participants will walk in the Lokomat with the VR for 21 minutes. After every 7 minutes, the speed of the OF will change (2 times the comfortable walking speed, equally to the comfortable walking speed, and 0.5 times the comfortable walking speed).

Stimulus poor VE

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy persons ≥ 55 years of age,
  • Normal or corrected-to-normal vision with glasses or contact lenses,
  • No locomotion impairments,
  • A maximal body weight of 135 kg,
  • A maximal body height of 200 cm

You may not qualify if:

  • Skin lesions that cannot be protected appropriately,
  • Significant lower extremity injuries during the last two years that might affect their gait,
  • Any type of vestibular/visual deficiency

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehabilitation center TrainM

Antwerp, 2018, Belgium

Location

Study Officials

  • Eric Kerckhofs, Prof. Ph.D

    Vrije Universiteit Brussel

    STUDY CHAIR
  • Eva Swinnen, Prof. Ph.D

    Vrije Universiteit Brussel

    STUDY DIRECTOR
  • Emma De Keersmaecker, Ph.D student

    Vrije Universiteit Brussel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctoral Researcher

Study Record Dates

First Submitted

February 19, 2018

First Posted

March 8, 2018

Study Start

September 12, 2018

Primary Completion

April 13, 2019

Study Completion

April 13, 2019

Last Updated

April 24, 2019

Record last verified: 2019-04

Locations